ATE315544T1 - Sertralin hydrochlorid form v - Google Patents

Sertralin hydrochlorid form v

Info

Publication number: ATE315544T1
Authority: AT; Austria
Prior art keywords: sertraline hydrochloride; sertraline; produced; hydrochloride; filtration
Prior art date: 1998-11-27

Application number

AT99959091T

Other languages

English (en)

Inventor

Eduard Schwartz

Tamar Nidam

Anita Liberman

Marioara Mendelovici

Jehudit Aronhime

Claude Singer

Evgeni Valdman

Original Assignee

Teva Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-11-27

Filing date

1999-11-24

Publication date

2006-02-15

1999-11-24 Application filed by Teva Pharma filed Critical Teva Pharma

2006-02-15 Application granted granted Critical

2006-02-15 Publication of ATE315544T1 publication Critical patent/ATE315544T1/de

Links

GLQPTZAAUROJMO-UHFFFAOYSA-N 4-(3,4-dimethoxyphenyl)benzaldehyde Chemical group C1=C(OC)C(OC)=CC=C1C1=CC=C(C=O)C=C1 GLQPTZAAUROJMO-UHFFFAOYSA-N 0.000 title abstract 12
229960003660 sertraline hydrochloride Drugs 0.000 abstract 7
WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 abstract 3
238000001914 filtration Methods 0.000 abstract 3
229960002073 sertraline Drugs 0.000 abstract 3
VGKDLMBJGBXTGI-SJCJKPOMSA-N sertraline Chemical compound C1([C@@H]2CC[C@@H](C3=CC=CC=C32)NC)=CC=C(Cl)C(Cl)=C1 VGKDLMBJGBXTGI-SJCJKPOMSA-N 0.000 abstract 3
238000010438 heat treatment Methods 0.000 abstract 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
235000019445 benzyl alcohol Nutrition 0.000 abstract 1
238000002425 crystallisation Methods 0.000 abstract 1
230000008025 crystallization Effects 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
239000003960 organic solvent Substances 0.000 abstract 1
230000020477 pH reduction Effects 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/33—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C211/39—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton
- C07C211/41—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems
- C07C211/42—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of an unsaturated carbon skeleton containing condensed ring systems with six-membered aromatic rings being part of the condensed ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT99959091T 1998-11-27 1999-11-24 Sertralin hydrochlorid form v ATE315544T1 (de)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date
US11011398P	1998-11-27	1998-11-27
US12517299P	1999-03-19	1999-03-19
US13311799P	1999-05-07	1999-05-07
US14788899P	1999-08-09	1999-08-09

Publications (1)

Publication Number	Publication Date
ATE315544T1 true ATE315544T1 (de)	2006-02-15

Family

ID=27493729

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99959091T ATE315544T1 (de)	1998-11-27	1999-11-24	Sertralin hydrochlorid form v

Country Status (9)

Country	Link
EP (1)	EP1133459B1 (de)
JP (1)	JP2002531427A (de)
AT (1)	ATE315544T1 (de)
AU (1)	AU1633600A (de)
DE (1)	DE69929462T2 (de)
ES (1)	ES2255320T3 (de)
HK (1)	HK1040979A1 (de)
IL (1)	IL143311A0 (de)
WO (1)	WO2000032551A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6500987B1 (en) *	1998-11-27	2002-12-31	Teva Pharmaceutical Industries Ltd.	Sertraline hydrochloride polymorphs
TWI260315B (en) *	1999-10-29	2006-08-21	Ciba Sc Holding Ag	Polymorphic forms of sertraline hydrochloride
US7442838B2 (en)	1999-10-29	2008-10-28	Ciba Specialty Chemicals Corp.	Polymorphic forms of sertraline hydrochloride
EP1772144A3 (de) *	1999-12-21	2007-08-15	Teva Pharmaceutical Industries Ltd	Neue Sertralinhydrochlorid Polymorphe, Verfahren zur Herstellung und zur Verwendung und diese enthaltende Zusammensetzungen
EP1797875A3 (de) *	1999-12-21	2007-08-29	Teva Pharmaceutical Industries Ltd	Neue Sertralinhydrochloridpolymorphe, Herstellungsverfahren dafür, Zusammensetzungen damit und Anwendungsverfahren
IN189886B (de) *	2000-03-29	2003-05-03	Sun Pharmaceutical Ind Ltd
IN192343B (de) *	2000-05-26	2004-04-10	Ranbaxy Lab Ltd
CA2448279A1 (en) *	2001-05-31	2002-12-05	Orion Corporation Fermion	Process for preparing sertraline hydrochloride polymorphic form ii
AU2003251290A1 (en) *	2002-04-29	2003-11-17	Teva Pharmaceutical Industries Ltd.	Process for preparation of polymorphic form ii of sertraline hydrochloride, pharmaceutical formulations and methods of administration thereof
PL376832A1 (pl) *	2002-11-07	2006-01-09	Torrent Pharmaceuticals Ltd.	Sposób wytwarzania polimorficznej postaci chlorowodorku sertraliny
WO2005000786A1 (en) *	2003-05-23	2005-01-06	Transform Pharmaceuticals, Inc.	Sertraline compositions
WO2008026644A1 (en)	2006-08-29	2008-03-06	Fujifilm Corporation	Hydrophilic matrix having poorly water-soluble compound sealed therein, and method for producing the same
EP3578546A1 (de)	2013-11-15	2019-12-11	Akebia Therapeutics Inc.	Feste formen von {[5-(3-chlorophenyl)-3-hydroxypyridin-2-carbonyl]amino}essigsäure, zusammensetzungen und verwendungen davon

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4536518A (en) *	1979-11-01	1985-08-20	Pfizer Inc.	Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US5082970A (en) *	1991-03-06	1992-01-21	Pfizer Inc.	Process for recycling amine isomer
GB9114947D0 (en) *	1991-07-11	1991-08-28	Pfizer Ltd	Process for preparing sertraline
US5248699A (en) *	1992-08-13	1993-09-28	Pfizer Inc.	Sertraline polymorph
US5734083A (en) *	1996-05-17	1998-03-31	Torcan Chemical Ltd.	Sertraline polymorph
JP2000026378A (ja) *	1998-07-03	2000-01-25	Sumika Fine Chemicals Co Ltd	塩酸セルトラリンの製法
TWI260315B (en) *	1999-10-29	2006-08-21	Ciba Sc Holding Ag	Polymorphic forms of sertraline hydrochloride

1999
- 1999-11-24 IL IL14331199A patent/IL143311A0/xx unknown
- 1999-11-24 EP EP99959091A patent/EP1133459B1/de not_active Expired - Lifetime
- 1999-11-24 AT AT99959091T patent/ATE315544T1/de not_active IP Right Cessation
- 1999-11-24 JP JP2000585193A patent/JP2002531427A/ja active Pending
- 1999-11-24 HK HK02102021.7A patent/HK1040979A1/zh unknown
- 1999-11-24 WO PCT/US1999/027881 patent/WO2000032551A1/en not_active Ceased
- 1999-11-24 DE DE69929462T patent/DE69929462T2/de not_active Expired - Fee Related
- 1999-11-24 AU AU16336/00A patent/AU1633600A/en not_active Abandoned
- 1999-11-24 ES ES99959091T patent/ES2255320T3/es not_active Expired - Lifetime

Also Published As

Publication number	Publication date
IL143311A0 (en)	2002-04-21
DE69929462D1 (de)	2006-04-06
DE69929462T2 (de)	2006-09-07
EP1133459A4 (de)	2004-09-29
EP1133459B1 (de)	2006-01-11
AU1633600A (en)	2000-06-19
EP1133459A1 (de)	2001-09-19
JP2002531427A (ja)	2002-09-24
WO2000032551A9 (en)	2001-07-19
ES2255320T3 (es)	2006-06-16
HK1040979A1 (zh)	2002-06-28
WO2000032551A1 (en)	2000-06-08

Similar Documents

Publication	Publication Date	Title
IS7308A (is)	2004-06-11	Nýr sertralínhýdróklóríðfjölgervingur og efnablanda sem inniheldur hann, nýjar aðferðir til að framleiða sertralínhýdróklóríðfjölgervinga og myndlausform
DE69929462D1 (de)	2006-04-06	Sertralin hydrochlorid form v
NO983970D0 (no)	1998-08-28	Tricykliske forbindelser, deres fremstilling og anvendelse
DE60040406D1 (de)	2008-11-13	Verfahren zur Herstellung der polymorphen Form II von Sertralin Hydrochlorid
SE0200730L (sv)	2002-08-29	Kristallin bas av citalopram
SI1781683T1 (sl)	2012-06-29	Postopek za pripravo 17-vinil-triflatov kot intermediatov
DE60234629D1 (de)	2010-01-14	Formoteroltartrat verfahren und polymorph
PT1181713E (pt)	2005-02-28	Metodo para preparacao de citalopram puro
BG106219A (bg)	2002-08-30	Метод за получаване на чист циталопрам
MY133531A (en)	2007-11-30	Synthesis of intermediates useful in preparing bromo-substituted tricyclic compounds
BR0209901A (pt)	2004-07-13	Processos para a sìntese de derivados de 2,3-dihidro-1,4-dioxino-[2,3-f] quinolina
ATE407111T1 (de)	2008-09-15	Isolierte atomoxetinverunreinigung, verfahren zur herstellung von atomoxetinverunreinigungen und deren verwendung als referenzstandards
EA200200939A1 (ru)	2003-02-27	Способ получения циталопрама
Spychała	1997	A facile preparation of N2-arylisocytosines
EA200501527A1 (ru)	2006-02-24	Способ получения полиморфа малеата розиглитазона
DE602005026827D1 (de)	2011-04-21	Verfahren zur herstellung von isoindolderivaten
YU51599A (sh)	2001-03-07	POSTUPAK I INTERMEDIJERI ZA β3-ADRENERGIČNI RECEPTORSKI AGONIST
UY26111A1 (es)	2000-12-29	Derivados de ciclobuten-3, 4-diona, su preparación y su aplicación en terapéutica
EP1302459A4 (de)	2004-03-10	Verfahren zur herstellung von annelierten pyrrolen
CA2377233A1 (en)	2001-01-04	Intermediates for the synthesis of benzimidazole compounds and process for the preparation thereof
CA2337248A1 (en)	2000-01-27	Process for the preparation of an indole derivative
DE60035194D1 (de)	2007-07-26	Verfahren zur herstellung von indol-derivaten und intermediaten dafür
DE60323052D1 (de)	2008-10-02	Zwei gonadotropin-freisetzende hormone und methode zur isolierung
ATE469119T1 (de)	2010-06-15	Verfahren zur herstellung von polymorphen von sertralin hydrochlorid
DE68914211D1 (de)	1994-05-05	Verfahren zur Herstellung von Zwischenprodukten in der Synthese von Diltiazem.

Legal Events

Date	Code	Title	Description
2006-07-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties